Abigail Geyer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11109 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-4539 |
Daniel W. Lovell, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4900 Saint Joe Rd, Fort Wayne, IN 46835 Phone: 260-969-1794 Fax: 260-969-3879 |
Stacy Waterman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11109 Parkview Plaza Drive, Pharmacy Department, Fort Wayne, IN 46845 Phone: 260-266-4400 |
Sarah Fitzpatrick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11109 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-4460 |
Karen Karen Dunkelberger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11109 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-4421 |
Benjamin Schortgen, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1900 Carew St Ste 4, Fort Wayne, IN 46805 Phone: 260-373-9775 Fax: 260-373-9789 |
Heather Ashley Rodman, PHARMD, BCPPS Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 11109 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-4491 Fax: 260-266-4463 |
Zsanett Kormanyos, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11109 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-1000 |
Sarah Beth Townsend Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6730 Bluffton Rd, Fort Wayne, IN 46809 Phone: 260-747-7563 |
Elahe Azimi Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6033 Sanctuary Ct, Fort Wayne, IN 46814 Phone: 260-672-9292 |
Thuy Vo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7408 Holden Dr, Fort Wayne, IN 46835 Phone: 260-417-7684 |
Shery I Grosjean, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11104 Parkview Circle Dr, Fort Wayne, IN 46845 Phone: 260-266-4545 |
Carla D Springer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7950 W Jefferson Blvd Ste 1b005, Fort Wayne, IN 46804 Phone: 260-432-3110 |
Dr. Logan D Anderson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10170 Maysville Rd, Fort Wayne, IN 46835 Phone: 260-486-7295 Fax: 939-526-0486 |
Christina Marie Anspach, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6202 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-432-5120 |
Dr. Kathleen Anne Smith, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6730 Bluffton Rd, Fort Wayne, IN 46809 Phone: 260-747-7563 Fax: 260-747-1909 |
Lynda Ikpeama Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 428 Wallen Hills Dr, Fort Wayne, IN 46825 Phone: 708-843-3854 |
Jennifer Gillingham, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6002 Saint Joe Center Rd, Fort Wayne, IN 46835 Phone: 260-492-2054 |
Megan A Dyer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2709 Northgate Blvd Apt 5, Fort Wayne, IN 46835 Phone: 765-202-2233 |
Christopher L Vice, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5110 Value Dr, Fort Wayne, IN 46808 Phone: 260-481-1100 |
News Archive
Pain distribution as reported on a body map, on its own, can be used to assign patients to distinct subgroups that are associated with differences in pain intensity, pain quality, pain impact and clinically-relevant three-month outcomes, according to a new study published this week in the open-access journal PLOS ONE by Benedict Alter of University of Pittsburgh, US, and colleagues.
AstraZeneca's new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel Pharmaceuticals, Inc., significantly improved outcomes of patients with rheumatoid arthritis who responded inadequately to ongoing treatment with methotrexate, according to phase II study data published in The New England Journal of Medicine today.
The novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China, last year and has since caused a large scale COVID-19 epidemic and spread to more than 70 other countries is the product of natural evolution, according to findings published today in the journal Nature Medicine.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has notified the Company that it is extending the Prescription Drug User Fee Act goal date for the Company's supplemental biologics license application for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease from September 6, 2013 to December 6, 2013.
› Verified 9 days ago